Related Experiment Video
Updated: Dec 31, 2025
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.0K
Percutaneous tumor ablation for hepatocellular carcinoma
Debra A Gervais1, Ronald S Arellano
1Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, White 270, 55 Fruit St, Boston, MA 02214, USA. dgervais@partners.org
AJR. American Journal of Roentgenology
|September 24, 2011
Summary
Hepatocellular carcinoma (HCC) is rising. Percutaneous ablation, including ethanol instillation and radiofrequency ablation, offers primary treatment or a bridge to liver transplantation, with new technologies emerging.
Area of Science:
- Hepatobiliary Medicine
- Interventional Radiology
- Oncology
Background:
- Hepatocellular carcinoma (HCC) incidence is increasing globally.
- Percutaneous ablation is a minimally invasive treatment modality for liver cancer.
- Current treatment strategies for HCC require continuous evaluation.
Purpose of the Study:
- To review the current clinical applications of percutaneous ablation for hepatocellular carcinoma.
- To assess the efficacy and safety of established and emerging percutaneous ablation techniques for HCC.
Main Methods:
- Literature review of clinical studies on percutaneous ablation for HCC.
- Analysis of data on percutaneous ethanol instillation (PEI) and radiofrequency ablation (RFA).
- Evaluation of novel percutaneous ablation technologies.
Main Results:
- Percutaneous ablation is a viable option for primary HCC treatment and as a bridge to liver transplantation.
- Percutaneous ethanol instillation and radiofrequency ablation are the most studied methods with established clinical roles.
- Emerging technologies show promise but require further clinical validation.
Conclusions:
- Percutaneous ablation techniques are crucial in managing the rising incidence of HCC.
- Established methods like PEI and RFA provide effective treatment options.
- Ongoing research into newer technologies may significantly impact future HCC management strategies.
